Cite
HARVARD Citation
Moulis, G. et al. (2022). Eltrombopag in adult patients with immune thrombocytopenia in the real‐world in France, including off‐label use before 6 months of disease duration: The multicenter, prospective ELEXTRA study. American journal of hematology. 97 (2), pp. E40-E44. [Online].